Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Gilead Sciences (NASDAQ:GILD) Stock Price Expected to Rise, BMO Capital Markets Analyst Says

Summary by marketbeat.com
BMO Capital Markets lifted their price target on Gilead Sciences from $130.00 to $135.00 and gave the stock an "outperform" rating in a report on Monday.

1 Articles

marketbeat.commarketbeat.com
Center

Gilead Sciences (NASDAQ:GILD) Stock Price Expected to Rise, BMO Capital Markets Analyst Says

BMO Capital Markets lifted their price target on Gilead Sciences from $130.00 to $135.00 and gave the stock an "outperform" rating in a report on Monday.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

marketbeat.com broke the news in on Monday, October 20, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Stock Markets icon

Stock Markets

Gilead Sciences icon

Gilead Sciences

News
For You
SearchBlindspotLocal